Corporate

Private equity and venture capital in Belgium

Published on 1st Feb 2018

Outlook for 2018

Following a very intense 2017, mainly at the mid-market level, Belgian M&A activity is set for a promising start in 2018:

  • Several studies and surveys confirmed that M&A in Belgium will continue to be powered by European and US private equity funds.
  • We expect that the on-going digital transformation will influence 2018 M&A activity with traditional, industrial, non-tech organisations willing to acquire digital companies and enter the digital era.
  • On the exit side, the healthcare and life science sector in Belgium has made an impressive start to the year with two takeovers of Belgian-listed biotech companies announced in the first days of January. Based on recent financial analysis, 6 to 8 of the 14 listed Belgian biotech companies are potential targets for acquisitions by international pharmaceutical groups.

Current market trends

The most active sectors in the Belgian PE/VC scene are the tech, media and comms, manufacturing, retail and life sciences/healthcare sectors. It is expected that this trend will continue in 2018.

FinTech continues to gain momentum in Belgium, with FinTech-specific accelerators being further developed and important international players like Moneygram moving to Belgium as a consequence of Brexit. We expect the FinTech sector to grow further in 2018, especially with the presence of business angels with a professional background in the FinTech sector looking for investment opportunities.

On 18 January, the Belgian Finance Minister announced he was working on a EUR 200M to 400M  new governmental ‘super fund’ that would invest in Belgian venture capital funds to finance local scale-ups. These governmental initiatives could fuel new PE/VC transactions for the coming years.

Legal and regulatory developments

A new Companies Code is expected to be adopted by Parliament in the course of this year (the “New Code“).

The New Code aims at implementing a more simple, modern and flexible Belgian corporate law to enable Belgium to become a more attractive place of business for both national and foreign companies.

The main aspects of this extensive reform include:

  • Reducing the number of company forms and structures;
  • Creating the possibility of issuing shares with multiple voting rights;
  • Modifying the provisions for the distribution of profits (adding, amongst others, a 12-month liquidity requirement to the current net assets test);
  • Changing the private limited liability company (SPRL/BVBA) into the preferred investment vehicle:
    • abolishing the capital requirements; and
    • providing a more flexible legal scheme to allow a SPRL/BVBA to be listed, and also to issue warrants and convertible bonds;
  • Increasing the mobility of companies:
    • setting up a registered office rule determining the nationality of the company (instead of the current effective management rule their head office or effective place of business conduct);
    • providing new inbound cross-border conversion or demergers (with continuation of legal personality) and outbound cross-border conversion procedures;
  • Introducing a general cap on directors’ liability (between EUR 125K and EUR 13M, depending on the company’s turnover and balance sheet total);
  • Increasing the flexibility of management :
    • allowing for four different management structures including a two-tier structure with supervisory board in SA/NV; and
    • allowing the removal of directors at will and their appointment in articles of association; and
  • Fine-tuning the reorganisation possibilities for Belgian companies.

Given the extensive upcoming changes, the New Code will affect every single Belgian company in various ways. This is a great opportunity to assess the arising challenges and newly-created opportunities.

The New Code should enter into force in the second half of 2018.  Companies will have 5 years to amend their articles of association and 10 years to convert into another company form (if necessary) but the mandatory rule changes will apply immediately.

Tax developments

A major tax reform, announced during the summer of 2017, entered into force as of 1 January 2018. This reform opens opportunities and potential threats. The main aspects relevant for PE/VC are:

  • the decrease of the corporate tax rate (in two steps, with the first decrease in 2018-2019 to 29.58%, then another decrease to 25% as from 2020),
  • the dividend exemption regime for a Belgian holding, increased from 95% to 100% as from 2018;
  • alignment of the 100% participation exemption of realized capital gains on shares with the conditions on the dividend exemption, introducing a new minimum participation threshold on the transferred participation (minimum 10%-shareholding, or acquisition value of 2.5 million euros);
  • reinforcment of the R&D and innovation incentives;
  • introduction of a tax consolidation mechanism (through group contributions) as of 2019;
  • implementation of the ATAD-Directives as of 2019, impacting the tax deduction of net interest charges.

Key deals in 2017

Our team in Brussels acted on the following PE/VC deals in 2017, advising:

  • Takeda Ventures on the extended Series A capital round of Univercells, an innovative bio manufacturing business based in Belgium
  • Accountable on corporate and tax shelter issues in the framework of its seed financing
  • A Belgian pharmaceutical company on the acquisition of a minority interest by PE investors and on its latest capital round
  • Investors on their tax treatment of proposed investments in (alternative) funds (real estate, tech, media and comms and pharma sectors)
  • An asset management firm on setting up a EUR 2M social impact bond program
  • An institutional investor at the exit-stage of an investment and its tax treatment
  • A technology company on its acquisition of an independent cybersecurity company
  • PE management companies on tax-related issues
  • A Belgian animal healthcare company on its new financing round including its issue of bonds redeemable by shares
Share

* This article is current as of the date of its publication and does not necessarily reflect the present state of the law or relevant regulation.

Connect with one of our experts

Interested in hearing more from Osborne Clarke?